Senior Manager of Accounting
Reporting to the Controller, the Senior Manager of Accounting will primarily be responsible for planning and driving the month-end close process for the Company’s clinical trial contracts. Candidate will be responsible for assessing, creating, and implementing operational improvements and streamlining existing processes as it relates to clinical trial accounting. Candidate should be detail-oriented, have strong communication skills, foster collaboration, and desire to be part of a team. Candidate should have the ability and desire to work in a fast-paced environment and handle multiple projects at once.
Responsibilities (including but not limited to):
- Monitor the financial health of the Company’s clinical trials, studies, programs, and related vendor contracts (project specifications, units, invoicing, change orders, accounting, and forecasting)
- Build and manage strong relationships with other functions within the Company, including FP&A and Clinical Operations, to ensure that accounting-relevant information is shared and processed in a timely manner, including, but not limited to, information regarding accruals
- Prepare and review accounting documentation, such as journal entries and account reconciliations, for clinical trial accruals and prepayments as part of the monthly and quarterly close process, ensure completeness and accuracy of documentation that supports journal entries and account reconciliations to create and maintain an audit trail
- Lead execution/utilization of clinical trial tracking system (Auxilius) for current and new clinical trials
- Incorporate real-time patient-driven data into clinical trial models
- Work with FP&A to perform monthly/quarterly analytical procedures to explain developments and trends of actuals compared to budget/forecast
- Assist Clinical Operations team with review of invoices to ensure timely payment of vendors
- Assist with the annual audit by interacting directly with the Company’s auditors related to clinical trial accruals
- Assist with special or ad-hoc projects as well as other finance related matters, as necessary
Qualifications:
- Bachelor’s degree in Accounting, CPA license a plus
- 7+ years of relevant and progressive experience, with a minimum of 3 years of clinical trial accounting experience
- Broad knowledge of accounting principles (US GAAP)
- Strong systems skills; experience with NetSuite; proficiency with Microsoft Excel; experience with clinical trial tracking systems a plus
- Ability to follow instructions for multiple projects with competing priorities and tight deadlines in a fast-paced environment
- Excellent interpersonal and communication skills
- Strong attention to detail, time management, and organizational skills
- Ability to work independently as well as with other groups across the business
About Dragonfly
Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel multispecific antibody technology to harness the body's immune system to bring breakthrough treatments to patients. In addition to its wholly owned clinical assets, Dragonfly has a deep pipeline of wholly owned preclinical candidates discovered using its proprietary platform, as well as productive collaborations with Merck, AbbVie, Gilead and Bristol Myers Squibb in a broad range of disease areas.
Our mission is to revolutionize disease treatment by inventing natural killer cell-based therapies for vastly improved patient outcomes. We believe in a small team with a big impact.
What We Do
Dragonfly Therapeutics is a clinical-stage biotech developing novel first-in-class therapeutics targeted at natural killer cells and other cells of the innate immune system. These therapies are designed to counterbalance immune suppressive factors present in the tumor microenvironment and mobilize anti-cancer immune responses. Our molecules are expected to be potent as single agents as well as in treatment combinations with existing cancer immunotherapies. Our scientific founders are major figures in cancer biology and immunology and have launched Dragonfly to harness the power of the immune system to provide breakthrough cancer treatments for patients. For more information, email [email protected].
